Log in
Enquire now
‌

US Patent 9017669 Anti-CDH3 antibodies and uses thereof

Patent 9017669 was granted and assigned to OncoTherapy Science, Inc. on April, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
OncoTherapy Science, Inc.
OncoTherapy Science, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9017669
Patent Inventor Names
Yusuke Nakamura0
Ryuji Ohsawa0
Shinji Yamamoto0
Yasuhiro Shiba0
Aiko Kudo0
Hiroki Yoshioka0
Keigo Endo0
Pohsing Ng0
Date of Patent
April 28, 2015
Patent Application Number
13519127
Date Filed
December 28, 2009
Patent Primary Examiner
‌
Maher Haddad
Patent abstract

The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9017669 Anti-CDH3 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us